NO20012738L - Terapeutiske produkter og anvendelse derav - Google Patents

Terapeutiske produkter og anvendelse derav

Info

Publication number
NO20012738L
NO20012738L NO20012738A NO20012738A NO20012738L NO 20012738 L NO20012738 L NO 20012738L NO 20012738 A NO20012738 A NO 20012738A NO 20012738 A NO20012738 A NO 20012738A NO 20012738 L NO20012738 L NO 20012738L
Authority
NO
Norway
Prior art keywords
therapeutic products
tramadol
sedation
racemate
dizziness
Prior art date
Application number
NO20012738A
Other languages
English (en)
Norwegian (no)
Other versions
NO20012738D0 (no
Inventor
Hazel Bardsley
Original Assignee
Darwin Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9826535.8A external-priority patent/GB9826535D0/en
Priority claimed from GBGB9826536.6A external-priority patent/GB9826536D0/en
Priority claimed from GBGB9826537.4A external-priority patent/GB9826537D0/en
Application filed by Darwin Discovery Ltd filed Critical Darwin Discovery Ltd
Publication of NO20012738D0 publication Critical patent/NO20012738D0/no
Publication of NO20012738L publication Critical patent/NO20012738L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
NO20012738A 1998-12-02 2001-06-01 Terapeutiske produkter og anvendelse derav NO20012738L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9826535.8A GB9826535D0 (en) 1998-12-02 1998-12-02 Therapeutic product and its use
GBGB9826536.6A GB9826536D0 (en) 1998-12-02 1998-12-02 Therapeutic product and its use
GBGB9826537.4A GB9826537D0 (en) 1998-12-02 1998-12-02 Therapeutic product and its use
PCT/GB1999/004021 WO2000032558A1 (en) 1998-12-02 1999-12-02 Therapeutic product and its use

Publications (2)

Publication Number Publication Date
NO20012738D0 NO20012738D0 (no) 2001-06-01
NO20012738L true NO20012738L (no) 2001-06-01

Family

ID=27269570

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20012738A NO20012738L (no) 1998-12-02 2001-06-01 Terapeutiske produkter og anvendelse derav

Country Status (12)

Country Link
EP (1) EP1135361A1 (ja)
JP (1) JP2002531431A (ja)
KR (1) KR20010080364A (ja)
CN (1) CN1329590A (ja)
AU (1) AU1400100A (ja)
BR (1) BR9915873A (ja)
CA (1) CA2350635A1 (ja)
HU (1) HUP0104420A2 (ja)
IL (1) IL142778A0 (ja)
NO (1) NO20012738L (ja)
PL (1) PL347542A1 (ja)
WO (1) WO2000032558A1 (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1164601A (en) 1999-11-09 2001-06-06 Darwin Discovery Limited Therapeutic use and formulation
KR20030059803A (ko) * 2000-10-03 2003-07-10 펜웨스트 파마슈티칼스 컴퍼니 다수의 약학적 활성 물질을 다양한 방출 속도로 전달하는시스템
DE10108122A1 (de) * 2001-02-21 2002-10-02 Gruenenthal Gmbh Arzneimittel auf Basis von Tramadol
WO2003048113A1 (en) 2001-11-30 2003-06-12 Sepracor Inc. Tramadol analogs and uses thereof
JP5269595B2 (ja) 2005-09-09 2013-08-21 アンジェリーニ ラボファーム リミテッド ライアビリティ カンパニー １日１回投与用トラゾドン組成物
EP2486921A1 (en) 2007-02-12 2012-08-15 DMI Biosciences, Inc. Reducing Side Effects of Tramadol
CN103936605B (zh) * 2007-05-31 2017-09-01 赛诺维信制药公司 苯基取代的环烷胺作为一元胺再摄取抑制剂
JOP20190251A1 (ar) * 2017-05-31 2019-10-21 Metys Pharmaceuticals AG تركيبات تآزرية تشتمل على (r)-ديميراسيتام (1) و(s)-ديميراسيتام (2) بنسبة غير راسيمية
WO2019113079A1 (en) 2017-12-05 2019-06-13 Sunovion Pharmaceuticals Inc. Nonracemic mixtures and uses thereof
EP3720435B1 (en) 2017-12-05 2024-03-06 Sunovion Pharmaceuticals Inc. Crystal forms and production methods thereof
US20220047587A1 (en) * 2018-12-04 2022-02-17 Metys Pharmaceuticals AG Synergistic compositions comprising r-2-(substituted-sulfonyl)-hexahydro-pyrrolo[1,2-a]pyrazin-6(2h)-ones and s-2-(substituted-sulfonyl)-hexahydro-pyrrolo[1,2-a]pyrazin-6(2h)-ones in a non-racemic ratio
US11160758B2 (en) 2019-06-04 2021-11-02 Sunovion Pharmaceuticals Inc. Modified release formulations and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5204116A (en) * 1991-05-01 1993-04-20 Alza Corporation Dosage form providing immediate therapy followed by prolonged therapy
IL131713A (en) * 1997-03-11 2004-08-31 Arakis Ltd Dosage forms comprising separate portions of r- and s-enantiomers
DE19807535A1 (de) * 1998-02-21 1999-08-26 Asta Medica Ag Pharmazeutische Kombinationen mit Tramadol

Also Published As

Publication number Publication date
HUP0104420A2 (en) 2002-08-28
IL142778A0 (en) 2002-03-10
PL347542A1 (en) 2002-04-08
CN1329590A (zh) 2002-01-02
BR9915873A (pt) 2001-08-21
JP2002531431A (ja) 2002-09-24
NO20012738D0 (no) 2001-06-01
WO2000032558A1 (en) 2000-06-08
AU1400100A (en) 2000-06-19
KR20010080364A (ko) 2001-08-22
CA2350635A1 (en) 2000-06-08
EP1135361A1 (en) 2001-09-26

Similar Documents

Publication Publication Date Title
NO20012738L (no) Terapeutiske produkter og anvendelse derav
DK1373215T3 (da) Gelanamycinderivater egnet til behandling af cancer
TR200102226T2 (tr) Formoterol ve bir tiotropium tuzunun kombinasyonları
DE60223254D1 (de) Verzögert freisetzende formulierungen von oxymorphon
NO20014303D0 (no) JAK-3-inhibitorer for behandling av allergiske lidelser
DK0858330T3 (da) Præparater indeholdende derivater af hydroperoxyeicosatetraensyre og fremgangsmåder til anvendelse ved behandling af sygdom
DK1212089T3 (da) Synergistisk kombination af Roflumilast og Salmeterol
IS6560A (is) Lyfjasamsetning fyrir meðhöndlun á bráðum, þrálátum sársauka og/eða taugakerfissársauka og mígreni
DK1311256T3 (da) Anvendelse af derivater af valproinsyreamider og 2-valproinsyreamider til behandling eller forebyggelse af smerter og/eller hovedpinelidelser
DE60037394D1 (de) VERWENDUNG VON p53 INHIBITOREN ZUR BEHANDLUNG VON NEBENERSCHEINUNGEN BEI DER KREBSTHERAPIE
NO20024891L (no) Farmasöytiske sammensetninger
IS4972A (is) Notkun klóbindiefnisins klíókínól við að framleiða lyfjablöndu til að meðhöndla Alzheimers-sjúkdóm
DK1363608T3 (da) Formuleringer omfattende ibuprofen og diphenhydramin og deres anvendelse til behandling af sovnforstyrrelser
AR032293A1 (es) Estuche farmaceutico
DK1228032T3 (da) Præparater, som indeholder hydroxyicosatetraensyrederivater, og fremgangsmåder til anvendelse ved behandling af öjentörhedslidelser
ATE260650T1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
DK1228028T3 (da) Hydroxyicosatetraenoatsalte, præparater og fremgangsmåder til anvendelse til behandling af öjentörhedslidelser
SE9802208D0 (sv) Novel compounds
NO20004818L (no) Stabile doseringsformer av fluoxetin og dets enantiomere
MXPA05012358A (es) Combinacion farmaceutica que comprende modafinilo y otra droga.
EE200300363A (et) N-(püridinüül)-1H-indool-1-amiinühendite kasutamine ravimi valmistamiseks, mis on ette nähtud müeliinikaotusega seotud haiguste ja seisundite ravimiseks
DE60102590T2 (de) Darreichungsformen zur behandlung von oralen mykosen
NO990440L (no) Preparat som innbefatter mupirocin og klorheksidin
HUP0000873A2 (hu) A levobupivakain arcsebészeti alkalmazása
ATE350032T1 (de) Verwendung der protein-kinase-c-epsilon- inhibitoren zur behandlung von schmerzen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application